Childhood Cancer

Childhood Cancer
Appendix C

Table C1.
New Jersey Childhood Cancer Incidence Rates,
All Races, Males and Females, Three-year Rates,
1980-1994

79-81 80-82 81-83 82-84 83-85 84-86 85-87 86-88 87-89 88-90 89-91 90-92 91-93 92-94 93-95

Total Cancer 14.2 14.8 16.1 16.7 16.0 14.7 14.3 14.6 14.6 15.4 16.1 16.5 16.1 15.3 15.0

Leukemia 4.8 5.0 5.2 5.2 4.9 4.4 4.4 4.3 4.3 4.6 4.5 4.5 4.5 4.5 4.5

Lymphocytic leukemia 3.6 3.9 4.0 4.0 3.5 3.2 3.1 3.2 3.5 3.7 3.6 3.6 3.7 3.7 3.6

Lymphoma 1.8 1.6 1.7 2.1 2.1 2.1 1.7 2.0 1.8 2.0 1.9 2.1 2.0 1.9 1.8

Hodgkin's lymphoma 0.9 0.6 0.6 0.7 0.9 0.7 0.8 0.8 0.7 0.9 0.8 0.9 0.8 0.8 0.7

Non-Hodgkin's lymphoma 0.5 0.5 0.5 0.7 0.7 0.8 0.5 0.7 0.6 0.7 0.6 0.6 0.7 0.7 0.7

Central Nervous System Tumor 2.4 2.7 3.4 3.6 3.6 3.0 3.0 3.1 3.3 3.3 3.3 3.5 3.5 3.3 3.1

Kidney Cancer 0.7 0.9 0.9 1.0 0.9 0.9 0.9 1.0 0.9 0.8 0.8 0.8 0.9 1.0 0.9

Bone Cancer 0.6 0.5 0.6 0.7 0.7 0.9 0.9 0.9 0.7 0.6 0.7 0.9 0.8 0.7 0.5

Soft-tissue Sarcoma 0.8 1.0 1.1 1.1 0.9 0.8 0.7 0.8 0.9 1.2 1.2 1.2 1.1 1.0 1.0

Table C2.
SEER Childhood Cancer Incidence Rates,
All Races, Males and Females, Three-year Rates,
1980-1994

79-81 80-82 81-83 82-84 83-85 84-86 85-87 86-88 87-89 88-90 89-91 90-92 91-93 92-94

Total Cancer 12.6 12.6 12.6 13.1 13.6 14.0 14.1 13.7 14.0 14.0 14.5 14.1 14.2 13.9

Leukemia 3.8 3.8 3.8 3.9 4.2 4.3 4.3 4.1 4.3 4.3 4.4 4.2 4.1 3.8

Lymphocytic leukemia 2.9 3.0 3.0 3.1 3.2 3.3 3.3 3.2 3.4 3.4 3.5 3.3 3.2 3.0

Lymphoma 1.5 1.5 1.6 1.6 1.7 1.6 1.7 1.6 1.6 1.5 1.5 1.5 1.5 1.5

Hodgkin's lymphoma 0.7 0.5 0.6 0.6 0.7 0.7 0.6 0.6 0.7 0.7 0.7 0.6 0.6 0.6

Non-Hodgkin's lymphoma 0.5 0.5 0.5 0.6 0.5 0.6 0.6 0.7 0.6 0.5 0.5 0.5 0.5 0.6

Central Nervous System Tumor 2.6 2.4 2.2 2.3 2.5 2.9 3.1 3.2 3.1 3.2 3.3 3.3 3.3 3.2

Kidney Cancer 0.8 0.8 0.9 0.9 0.8 0.8 0.8 0.8 0.9 0.8 0.9 0.8 0.7 0.9

Bone Cancer 0.7 0.7 0.7 0.7 0.7 0.7 0.8 0.7 0.7 0.6 0.7 0.7 0.7 0.6

Soft-tissue Sarcoma 0.8 0.9 0.9 1.0 1.0 1.0 1.0 0.9 0.9 1.0 1.2 1.1 1.0 0.9

Table C3.
New Jersey Childhood Cancer Mortality Trends,
All Races, Males and Females,
1980-1994

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994

Total Cancer 4.2 4.1 4.4 4.5 4.1 4.0 3.8 4.0 3.5 3.2 2.8 2.7 2.6 2.7 3.0

Leukemia 1.5 1.4 1.3 1.4 1.5 1.7 1.7 1.6 1.2 1.0 0.8 0.9 0.9 0.9 0.9

Lymphocytic leukemia 1.0 0.9 0.8 0.8 0.7 0.8 0.8 0.8 0.7 0.6 0.5 0.5 0.4 0.5 0.5

Lymphoma 0.3 0.3 0.5 0.4 0.3 0.1 0.2 0.2 0.3 0.2 0.2 0.2 0.1 0.1 0.2

Hodgkin's lymphoma 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0

Non-Hodgkin's lymphoma 0.3 0.2 0.4 0.3 0.2 0.1 0.2 0.2 0.3 0.2 0.2 0.2 0.1 0.1 0.2

Central Nervous System Tumor 0.9 0.9 1.2 1.4 1.3 1.1 0.8 1.0 0.9 1.0 0.9 0.8 0.7 0.7 0.9

Kidney Cancer 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.1

Bone Cancer 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0

Soft-tissue Sarcoma 0.2 0.2 0.3 0.3 0.2 0.1 0.2 0.1 0.2 0.2 0.2 0.1 0.1 0.2 0.2

Table C4.
United States Childhood Cancer Mortality Trends,
All Races, Males and Females,
1980-1994

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994

Total Cancer 4.3 4.1 4.2 4.2 3.5 3.4 3.4 3.4 3.2 3.2 3.1 3.1 2.9 3.0 2.9

Leukemia 1.8 1.6 1.7 1.6 1.3 1.3 1.3 1.3 1.1 1.1 1.0 1.1 1.2 1.0 1.0

Lymphocytic leukemia 1.0 0.9 0.8 0.9 0.7 0.7 0.7 0.7 0.5 0.6 0.6 0.5 0.5 0.5 0.5

Lymphoma 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.1

Hodgkin's lymphoma 0.7 0.9 1.0 1.0 0.9 0.9 0.9 1.0 0.9 0.9 0.8 0.9 1.0 1.0 0.8

Non-Hodgkin's lymphoma 0.2 0.2 0.1 0.2 0.2 0.1 0.1 0.3 0.1 0.2 0.2 0.1 0.1 0.1 0.1

Central Nervous System Tumor 0.9 0.8 1.0 0.8 0.8 0.8 0.8 0.7 0.8 0.9 0.8 0.8 0.8 0.7 0.8

Kidney Cancer 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0

Bone Cancer 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1

Soft-tissue Sarcoma 0.2 0.2 0.1 0.2 0.2 0.1 0.1 0.3 0.1 0.2 0.2 0.1 0.1 0.1 0.1

	79-81	80-82	81-83	82-84	83-85	84-86	85-87	86-88	87-89	88-90	89-91	90-92	91-93	92-94	93-95
Total Cancer	14.2	14.8	16.1	16.7	16.0	14.7	14.3	14.6	14.6	15.4	16.1	16.5	16.1	15.3	15.0
Leukemia	4.8	5.0	5.2	5.2	4.9	4.4	4.4	4.3	4.3	4.6	4.5	4.5	4.5	4.5	4.5
Lymphocytic leukemia	3.6	3.9	4.0	4.0	3.5	3.2	3.1	3.2	3.5	3.7	3.6	3.6	3.7	3.7	3.6
Lymphoma	1.8	1.6	1.7	2.1	2.1	2.1	1.7	2.0	1.8	2.0	1.9	2.1	2.0	1.9	1.8
Hodgkin's lymphoma	0.9	0.6	0.6	0.7	0.9	0.7	0.8	0.8	0.7	0.9	0.8	0.9	0.8	0.8	0.7
Non-Hodgkin's lymphoma	0.5	0.5	0.5	0.7	0.7	0.8	0.5	0.7	0.6	0.7	0.6	0.6	0.7	0.7	0.7
Central Nervous System Tumor	2.4	2.7	3.4	3.6	3.6	3.0	3.0	3.1	3.3	3.3	3.3	3.5	3.5	3.3	3.1
Kidney Cancer	0.7	0.9	0.9	1.0	0.9	0.9	0.9	1.0	0.9	0.8	0.8	0.8	0.9	1.0	0.9
Bone Cancer	0.6	0.5	0.6	0.7	0.7	0.9	0.9	0.9	0.7	0.6	0.7	0.9	0.8	0.7	0.5
Soft-tissue Sarcoma	0.8	1.0	1.1	1.1	0.9	0.8	0.7	0.8	0.9	1.2	1.2	1.2	1.1	1.0	1.0

	1980	1981	1982	1983	1984	1985	1986	1987	1988	1989	1990	1991	1992	1993	1994
Total Cancer	4.2	4.1	4.4	4.5	4.1	4.0	3.8	4.0	3.5	3.2	2.8	2.7	2.6	2.7	3.0
Leukemia	1.5	1.4	1.3	1.4	1.5	1.7	1.7	1.6	1.2	1.0	0.8	0.9	0.9	0.9	0.9
Lymphocytic leukemia	1.0	0.9	0.8	0.8	0.7	0.8	0.8	0.8	0.7	0.6	0.5	0.5	0.4	0.5	0.5
Lymphoma	0.3	0.3	0.5	0.4	0.3	0.1	0.2	0.2	0.3	0.2	0.2	0.2	0.1	0.1	0.2
Hodgkin's lymphoma	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Non-Hodgkin's lymphoma	0.3	0.2	0.4	0.3	0.2	0.1	0.2	0.2	0.3	0.2	0.2	0.2	0.1	0.1	0.2
Central Nervous System Tumor	0.9	0.9	1.2	1.4	1.3	1.1	0.8	1.0	0.9	1.0	0.9	0.8	0.7	0.7	0.9
Kidney Cancer	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.1
Bone Cancer	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0
Soft-tissue Sarcoma	0.2	0.2	0.3	0.3	0.2	0.1	0.2	0.1	0.2	0.2	0.2	0.1	0.1	0.2	0.2